Should you buy, hold, or sell CBA, CSL, and Pilbara Minerals shares?

Let's see what analysts are saying about these big names.

| More on:
Middle age caucasian man smiling confident drinking coffee at home.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are 200 shares for investors to choose from on the ASX 200 index.

To narrow things down for investors, let's take a look at three very popular shares that Fairmont Equities has given its verdict on, courtesy of The Bull.

Here's what it is saying about these giants:

Commonwealth Bank of Australia (ASX: CBA)

Fairmont Equities was bullish on Australia's largest bank last year and benefited from its record-breaking rally.

However, with its shares looking expensive and its share price chart showing signs of weakness, it feels that now is the time to sell. It explains:

We turned bullish on CBA in early 2024 as it broke above a major resistance level and started to rally. We remained bullish until recently when the share price chart finally showed signs of weakness. This also coincides with long held investor concerns around CBA's valuation. While we didn't sell CBA on valuation grounds and rode it higher in the past 18 months, a topping signal on the chart is a sign to finally exit this position, in our view.

CSL Ltd (ASX: CSL)

Another ASX 200 share that Fairmont Equities has been looking at is biotherapeutics giant CSL.

Its analysts note that the company's shares have been recovering in recent months. And while they have stopped short of calling it a buy, they think it would be one to hold tightly to for the future. They explain:

This global biotechnology giant provides medicines to patients in more than 100 countries. The company makes vaccines to prevent influenza. Its medicines treat haemophilia and immune deficiencies, and it offers therapies in iron deficiency and nephrology. The share price is starting to recover from its lows in response to mixed first half results in fiscal year 2025 and uncertainty surrounding US tariffs. The shares have risen from $234.34 on June 27 to trade at $271.56 on July 31. We view CSL as a solid hold for capital growth and income.

Pilbara Minerals Ltd (ASX: PLS)

Finally, Fairmont Equities has been looking at lithium giant Pilbara Minerals.

Its analysts are optimistic that a recovery could be on the cards for its shares. However, they are not confident enough to call it a buy just yet and instead rate Pilbara Minerals as a hold. They said:

Most lithium miners have rallied well in the past few weeks and there are signs the sector is at or near the bottom. Like most lithium miners, PLS had been trending lower for the past two years, but it recently reached a new peak on the share price chart by breaking above the May high on good volume. It's early days, but this could be the first step in PLS breaking the downtrend and embarking on a likely recovery.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

White declining arrow on a blue graph with an animated man representing a falling share price.
Materials Shares

Experts call time on these rip-snorting ASX 200 mining shares

These 2 ASX 200 mining stocks have risen by 160% and 230%, respectively, over the past 12 months.

Read more »

Two people comparing and analysing material.
Broker Notes

Buy, hold, sell: Netwealth, Santos, and South32 shares

Morgans has given its verdict on these shares following updates.

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Broker says this ASX All Ords stock could rise 15%

Bell Potter thinks investors should be buying this growing company's shares.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why Lynas shares could crash 33%

Bell Potter believes this rare earths stock could lose a third of its value.

Read more »

Three girls compete in a race, running fast around an athletic track.
Broker Notes

Two ASX 200 stocks to buy after crashing 6-9% yesterday

Bell Potter is tipping an 18-40% resurgence for these stocks.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Broker Notes

Looking for double-digit returns? Check out RBC Capital Markets' picks ahead of reporting season

These shares could deliver strong upside.

Read more »